Get complete Patent Opposition Report for Valneva Austria

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Valneva Austria against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3564378Immunogenic CompositionGLAXOSMITHKLINE BIOLOGICALSJul 25, 2024
EP3138916Immunogenic CompositionGLAXOSMITHKLINE BIOLOGICALSMar 16, 2020

Explore Valneva Austria's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3785730Apr 24, 2024Aluminium Compounds For Use In Therapeutics And Vaccines1
EP3393510Feb 22, 2023Zika Virus Vaccine1
EP3269386Sep 14, 2022Aluminium Compounds For Use In Therapeutics And Vaccines1
EP3106176Oct 11, 2017Aluminium Compounds For Use In Therapeutics And Vaccines1